Celltrion – Talk Bio

Actionable Insights Powered by AI

Amgen and Celltrion Reach Settlement in Denosumab Patent Litigation, Paving Way for Mid-2025 Biosimilar Launch

Amgen, Celltrion, denosumab, patent litigation, biosimilar, settlement, launch date